CA
INSM icon

Cannon Advisors’s Insmed INSM Stock Holding History

Cannon Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$663K Buy
+6,018
New +$729K 0.4% 56

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Cannon Advisors's INSM Position: Q2 2026 in Review

Cannon Advisors opened a new position in Insmed (INSM) in Q2 2026: 6,018 shares worth $663K. The stake represents 0.4% of the portfolio and ranks #56 among its holdings.

666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Cannon Advisors held 6,018 shares of Insmed worth $663K as of Q2 2026.
  • Insmed was a new Cannon Advisors position in Q2 2026.
  • Insmed made up 0.4% of Cannon Advisors's portfolio in Q2 2026, its #56 holding.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Cannon Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.